mRNA profiling of mock casework samples: Results of a FoRNAP collaborative exercise.


Journal

Forensic science international. Genetics
ISSN: 1878-0326
Titre abrégé: Forensic Sci Int Genet
Pays: Netherlands
ID NLM: 101317016

Informations de publication

Date de publication:
01 2021
Historique:
received: 14 05 2020
revised: 02 10 2020
accepted: 12 10 2020
pubmed: 22 11 2020
medline: 6 7 2021
entrez: 21 11 2020
Statut: ppublish

Résumé

In recent years, forensic mRNA profiling has increasingly been used to identify the origin of human body fluids. By now, several laboratories have implemented mRNA profiling and also use it in criminal casework. In 2018 the FoRNAP (Forensic RNA Profiling) group was established among a number of these laboratories with the aim of sharing experiences, discussing optimization potential, identifying challenges and suggesting solutions with regards to mRNA profiling and casework. To compare mRNA profiling methods and results a collaborative exercise was organized within the FoRNAP group. Seven laboratories from four countries received 16 stains, comprising six pure body fluid / tissue stains and ten mock casework samples. The laboratories were asked to analyze the provided stains with their in-house method (PCR/CE or MPS) and markers of choice. Five laboratories used a DNA/RNA co-extraction strategy. Overall, up to 11 mRNA markers per body fluid were analyzed. We found that mRNA profiling using different extraction and analysis methods as well as different multiplexes can be applied to casework-like samples. In general, high input samples were typed with high accuracy by all laboratories, regardless of the method used. Irrespective of the analysis strategy, samples of low input or mixed stains were more challenging to analyze and interpret since, alike to DNA profiling, a higher number of markers dropped out and/or additional unexpected markers not consistent with the cell type in question were detected. It could be shown that a plethora of different but valid analysis and interpretation strategies exist and are successfully applied in the Forensic Genetics community. Nevertheless, efforts aiming at optimizing and harmonizing interpretation approaches in order to achieve a higher consistency between laboratories might be desirable in the future. The simultaneous extraction of DNA alongside RNA showed to be an effective approach to identify not only the body fluid present but also to identify the donor(s) of the stain. This allows investigators to gain valuable information about the origin of crime scene samples and the course of events in a crime case.

Identifiants

pubmed: 33220528
pii: S1872-4973(20)30181-2
doi: 10.1016/j.fsigen.2020.102409
pii:
doi:

Substances chimiques

Genetic Markers 0
RNA, Messenger 0
DNA 9007-49-2

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

102409

Informations de copyright

Copyright © 2020 The Authors. Published by Elsevier B.V. All rights reserved.

Auteurs

Andrea Patrizia Salzmann (AP)

Zurich Institute of Forensic Medicine, University of Zurich, Switzerland.

Malte Bamberg (M)

Institute of Legal Medicine, University Hospital, University of Ulm, Germany.

Cornelius Courts (C)

Institute of Forensic Medicine, University Hospital of Schleswig-Holstein, Kiel, Germany.

Guro Dørum (G)

Zurich Institute of Forensic Medicine, University of Zurich, Switzerland.

Annica Gosch (A)

Institute of Forensic Medicine, University Hospital of Schleswig-Holstein, Kiel, Germany.

Thorsten Hadrys (T)

Bavarian State Criminal Police Office, Institute of Forensic Sciences, Munich, Germany.

Gavrilo Hadzic (G)

National Forensic Laboratory, Police, Slovenia.

Maximilian Neis (M)

Institute of Legal Medicine, Faculty of Medicine, University Hospital, University of Cologne, Germany.

Peter M Schneider (PM)

Institute of Legal Medicine, Faculty of Medicine, University Hospital, University of Cologne, Germany.

Titia Sijen (T)

Netherlands Forensic Institute, The Hague, the Netherlands.

Margreet van den Berge (MV)

Netherlands Forensic Institute, The Hague, the Netherlands.

Peter Wiegand (P)

Institute of Legal Medicine, University Hospital, University of Ulm, Germany.

Cordula Haas (C)

Zurich Institute of Forensic Medicine, University of Zurich, Switzerland. Electronic address: cordula.haas@irm.uzh.ch.

Articles similaires

Genome, Chloroplast Phylogeny Genetic Markers Base Composition High-Throughput Nucleotide Sequencing

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C

Classifications MeSH